Grants 2007
Janssen Pharmaceutica NV, a division of Johnson & Johnson Pharmaceutical
“Testing four JNJ compounds against a panel of ten breast cancer cell lines”
PI: Mieke Schutte, John Martens and John Foekens
€ 12.000
Erasmus MC, Mrace translational research grant
“Prognostic breast cancer classification by high coverage mutation profiling”
PI: Mieke Schutte, Wilfred van IJcken, John Martens and Andrew Stubbs
€ 50.000
Top Institute Pharma ‘07-‘11, T3-108 –-Dutch government
“Predicting drug responses in breast cancer”
PI: L.J. van ‘t Veer, I. Simon, J.G.M. Klijn, J.A. Foekens, E.M.J.J. Berns
€ 3.980.000
Association for international cancer research (AICR)
“Clinical significance of microRNAs in breast cancer”
PI’s: J.W.M. Martens, E.A.C. Wiemer, J. A. Foekens
National Genomics Initiative (NGI) ‘08-’11; Dutch government
“Cancer Genomics Centre (CGC) part 2 (including Junior CGC programme)”
Chairman J.L. Bos; Participants: NKI, Amsterdam, UMC, Utrecht, Hubrecht Laboratory, Utrecht, and Erasmus MC, Rotterdam, PI: J.A. Foekens
Susan G. Komen Breast Cancer Foundation (BCTR127606)
"Defining the clinical and functional role of an extracellular matrix gene cluster in therapy failure"
PI: Els Berns
$ 250.000